Drug importers have indicated that several hundred essential drugs not produced in Lebanon are now missing from the Lebanese population as a dispute has arisen between the Ministry of Health and the Bank of Lebanon over the financing of subsidies to this sector. yet essential. Thus the Bank of Lebanon estimates the cost of these drugs at 485 million dollars against an estimate of 600 million dollars according to the ministry.
According to importers, virtually no imports took place last month, when the Banque du Liban even refused to grant the lines of credit necessary to pay the pharmaceutical companies.
Some drugs including for the benefit of patients with chronic diseases are lacking in the market including treatments related to hypertension, diabetes and even cancer. This situation could even be catastrophic at the end of July with possible deaths for lack of being able to treat these people.
